XDH and metabolic dysfunction-associated steatohepatitis: This reduction in hepatic UA levels and XO activity was accompanied by more effective prevention of certain features of NASH, including insulin resistance, lipid peroxidation, classically activated M1-like macrophage accumulation, and liver inflammation.